|
The Company hereby provides this immediate report that it was approved for a grant from The Michael J. Fox Foundation for Parkinson's Research >
|
Success in Phase II clinical studies with the Accordion Pill Carbidopa Levodopa product for the treatment of Parkinson’s disease >
|
Completion of the construction of the new production line for Phase III clinical trials >
|
|
Success in Phase II clinical trial with the Accordion-Zaleplon product for the treatment of sleep disorders >
|
Successful intermediate results of Phase IIb clinical trial with Accordion Pill-Carbidopa/Levodopa for Parkinson’s disease, second group >
|
|
Success in the first group of patients in Phase II clinical trials for the Accordion Pill Zaleplon for sleep disorders, intermediate results >
|
|
FDA approval for commencing Phase II trials in the US for the Accordion- Zaleplon for Sleep Disorders >
|
|
Success of Phase II b Clinical Trial with the Accordion-Pill-Levodopa Product, for the Treatment of Parkinson's disease Symptoms – Intermediate Results >
|
Intec Pharma announced the successful completion of phase I clinical studies with its Accordion-Pill Baclofen
(AP-Baclofen) >
|
|
Huge success in the Initial Public Offering of Intec Pharma >
|
|
Intec Pharma announces successful completion of Phase IIA with its AP-CD/LD >
|
